Use of gene expression profiling to predict survival in cancer patient
    2.
    发明申请
    Use of gene expression profiling to predict survival in cancer patient 有权
    使用基因表达谱来预测癌症患者的存活

    公开(公告)号:US20060003365A1

    公开(公告)日:2006-01-05

    申请号:US11147829

    申请日:2005-06-08

    IPC分类号: C12Q1/68

    摘要: Gene expression profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment. Poor survival is linked to over-expression of genes such as ASPM, OPN3 and CKS1B which are located in chromosome 1q. Given the frequent amplification of 1q in many cancers, it is possible that these genes can be used as powerful prognostic markers and therapeutic targets for multiple myeloma and other cancer.

    摘要翻译: 在多发性骨髓瘤患者中进行基因表达谱分析鉴定了随后早期死亡或治疗后长期存活的患者之间区分的基因。 差的存活与位于染色体1q的基因如ASPM,OPN3和CKS1B的过表达有关。 鉴于许多癌症中1q的频繁扩增,这些基因可能被用作多种骨髓瘤和其他癌症的强大的预后标志物和治疗靶点。

    DYNAMIC NETWORK LINK ACCELERATION FOR NETWORK INCLUDING WIRELESS COMMUNICATION DEVICES
    3.
    发明申请
    DYNAMIC NETWORK LINK ACCELERATION FOR NETWORK INCLUDING WIRELESS COMMUNICATION DEVICES 有权
    网络的动态网络链接加速,包括无线通信设备

    公开(公告)号:US20120290642A1

    公开(公告)日:2012-11-15

    申请号:US13486347

    申请日:2012-06-01

    IPC分类号: G06F15/16

    摘要: A method and apparatus for dynamic network link acceleration provides a managed communication link for accelerated and reliable network communication between a client and other network devices. In one or more embodiments, a client computing device which generates communication packets of a first type is enhanced with a front end mechanism which selectively encodes the data packets into packets of a second type. The data packets which are encoded into a second type are transmitted over a managed communication link which may provide error correction, security, quality of service, and other services including acceleration of communications.

    摘要翻译: 用于动态网络链路加速的方法和装置提供用于客户端和其他网络设备之间的加速和可靠的网络通信的被管理的通信链路。 在一个或多个实施例中,生成第一类型的通信分组的客户端计算设备通过前端机制增强,前端机制将数据分组选择性地编码为第二类型的分组。 编码为第二类型的数据分组通过可提供纠错,安全性,服务质量以及包括通信加速在内的其它服务的管理通信链路来发送。

    Molecular determinants of myeloma bone disease and uses thereof
    4.
    发明申请
    Molecular determinants of myeloma bone disease and uses thereof 失效
    骨髓瘤骨病的分子决定因素及其用途

    公开(公告)号:US20060019895A1

    公开(公告)日:2006-01-26

    申请号:US11176739

    申请日:2005-07-07

    申请人: John Shaughnessy

    发明人: John Shaughnessy

    IPC分类号: A61K38/54 C12Q1/68

    摘要: To identify molecular determinants of lytic bone disease in multiple myeloma, the expression profiles of ˜12,000 genes in CD138-enriched plasma cells from newly diagnosed multiple myeloma patients exhibiting no radiological evidence of lytic lesions (n=28) were compared to those with ≧3 lytic lesions (n=47). Two secreted WNT signaling antagonists, soluble frizzled related protein 3 (SFRP-3/FRZB) and the human homologue of Dickkopf-1 (DKK1), were expressed in 40 of 47 with lytic bone lesions, but only 16 of 28 lacking bone lesions (P

    摘要翻译: 为了鉴定多发性骨髓瘤中溶骨性疾病的分子决定因素,将新发诊断多发性骨髓瘤患者的CD138富集血浆细胞中〜12,000个基因的表达谱与没有溶解性病变的放射学证据(n = 28)进行比较, 3例溶解性病变(n = 47)。 两个分泌的WNT信号传导拮抗剂,可溶性卷曲相关蛋白3(SFRP-3 / FRZB)和Dickkopf-1(DKK1)的人类同源物在47例中具有溶骨病变,但在28例缺乏骨病变中仅有16例 P <0.05)。 DKK1和FRZB在来自45个正常骨髓供体的血浆细胞中不表达,或10个Waldenstrom的巨球蛋白血症,一种缺乏骨病的相关浆细胞恶性肿瘤。 这些数据表明这些因素是多发性骨髓瘤骨病的重要介质,这些蛋白质的抑制剂可用于阻断骨骼疾病。

    Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
    5.
    发明申请
    Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling 有权
    基于基因表达谱的多发性骨髓瘤的潜在治疗靶点的诊断,预后和鉴定

    公开(公告)号:US20050282192A1

    公开(公告)日:2005-12-22

    申请号:US11110209

    申请日:2005-04-20

    IPC分类号: C12Q1/68 G06F19/00

    摘要: Gene expression profiling is a powerful tool that has varied utility. It enables classification of multiple myeloma into subtypes and identifing genes directly involved in disease pathogensis and clinical manifestation. The present invention used gene expression profiling in large uniformly treated population of patients with myeloma to identify genes associated with poor prognosis. It also demonstrated that over-expression of CKS1B gene, mainly due to gene amplification that was determined by Fluorescent in-situ hybridization to impart a poor prognosis in multiple myleoma. It is further contemplated that therapeutic strategies that directly target CKS1B or related pathways may represent novel, and more specific means of treating high risk myeloma and may prevent its secondary evolution.

    摘要翻译: 基因表达谱是一种功能多样的强大工具。 它可以将多发性骨髓瘤分类为亚型,并确定直接参与疾病病理和临床表现的基因。 本发明在大量均匀治疗的骨髓瘤患者群中使用基因表达谱来鉴定与预后不良相关的基因。 它还表明CKS1B基因的过表达,主要是由于通过荧光原位杂交确定的基因扩增,以在多种myleoma中预后不良。 进一步预期,直接靶向CKS1B或相关途径的治疗策略可以代表治疗高风险骨髓瘤的新颖和更具体的手段,并且可以防止其二次进化。

    Use of gene expression profiling to predict survival in cancer patient
    6.
    发明申请
    Use of gene expression profiling to predict survival in cancer patient 有权
    使用基因表达谱来预测癌症患者的存活

    公开(公告)号:US20050260664A1

    公开(公告)日:2005-11-24

    申请号:US11133937

    申请日:2005-05-20

    IPC分类号: C12Q1/68

    摘要: Gene expression profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment. Poor survival is linked to over-expression of genes such as ASPM, OPN3 and CKS1B which are located in chromosome 1q. Given the frequent amplification of 1q in many cancers, it is possible that these genes can be used as powerful prognostic markers and therapeutic targets for multiple myeloma and other cancer.

    摘要翻译: 在多发性骨髓瘤患者中进行基因表达谱分析鉴定了随后早期死亡或治疗后长期存活的患者之间区分的基因。 差的存活与位于染色体1q的基因如ASPM,OPN3和CKS1B的过表达有关。 鉴于许多癌症中1q的频繁扩增,这些基因可能被用作多种骨髓瘤和其他癌症的强大的预后标志物和治疗靶点。

    Dynamic network link acceleration
    9.
    发明申请
    Dynamic network link acceleration 有权
    动态网络链接加速

    公开(公告)号:US20100011116A1

    公开(公告)日:2010-01-14

    申请号:US12584938

    申请日:2009-09-14

    IPC分类号: G06F15/16 H03M13/09

    摘要: A method and apparatus for dynamic network link acceleration provides a managed communication link for accelerated and reliable network communication between a client and other network devices on demand. In one or more embodiments, the system comprises an enhanced client capable of providing front-end services. The enhanced client may establish the communication link with a back-end mechanism. The communication link may provide error correction, security, quality of service, and other services including acceleration of communications. In one embodiment, the enhanced client provides a communication link utilizing the TMP protocol by cooperative action with a back-end mechanism. A client may be various computing or network devices and may be enhanced with front-end services automatically by automatic download and installation of an internal front-end or manually by user installation of an internal front-end. In one or more embodiments, the front-end services software utilizes hardware of an enhanced client to provide the communication link.

    摘要翻译: 一种用于动态网络链路加速的方法和装置提供了一种用于在客户端和其他网络设备之间进行加速和可靠的网络通信的托管通信链路。 在一个或多个实施例中,该系统包括能够提供前端服务的增强型客户机。 增强的客户端可以建立与后端机制的通信链路。 通信链路可以提供纠错,安全性,服务质量以及包括加速通信在内的其他服务。 在一个实施例中,增强型客户端通过与后端机制的协作动作来提供利用TMP协议的通信链路。 客户端可以是各种计算机或网络设备,并且可以通过内部前端的自动下载和安装或通过用户安装内部前端手动自动地增强前端服务。 在一个或多个实施例中,前端服务软件利用增强型客户机的硬件来提供通信链路。